Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,476–5,500 of 7,816 matching trials · page 220 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Alzheimer's Disease: Potential Benefit of Isoflavones NCT00205179 Novasoy; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 72 | University of Wisconsin, Madison OTHER |
2020-01-22 |
|
Brain Stimulation in Movement Disorders NCT02216474 Transcranial direct current stimulation Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 20 | Birmingham and Solihull Mental Health NHS Foundation Trust OTHER |
2020-01-22 |
|
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers NCT03698695 THN 201; Donepezil; Placebo Runs in: France · 7 sites |
PHASE1 symptomatic-cholinergic |
COMPLETED | 152 | Theranexus INDUSTRY |
2020-01-22 |
|
Emotional Regulation in Patients With Implanted Automatic Defibrillator NCT04235881 Mindfulness-based stress reduction program; App REM volver a casa Runs in: Spain · 1 site |
NA other |
COMPLETED | 96 | Instituto de Investigación Hospital Universitario La Paz OTHER |
2020-01-22 |
|
Improving Performance in Drivers With Mild Cognitive Impairment NCT01935219 Goal Management Training; Processing Speed Training; Brain Health Workshop Runs in: Canada · 1 site |
NA other |
COMPLETED | 66 | Baycrest OTHER |
2020-01-21 |
|
Investigating the Clinical Consequences of Flutemetamol-PET-scanning NCT02353949 Flutemetamol (Vizamyl) Runs in: Switzerland · 1 site |
PHASE3 other |
TERMINATED | 11 | University of Zurich OTHER |
2020-01-21 |
|
Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI NCT02864069 Walking Intervention; Cognitive Training Intervention; Combined Int... Runs in: United States · 1 site |
NA other |
COMPLETED | 52 | University of California, San Diego OTHER |
2020-01-18 |
|
The Effect of tES on a Cognitive Training NCT03475446 real anodal tDCS healthy elderly; real tACS healthy elderly; sham t... Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 65 | University of Bern OTHER |
2020-01-18 |
|
Pilot Study About Extra Virgin Olive Oil "Coratina" in Mild Cognitive Impairment and Alzheimer's Disease Patients NCT04229186 EVOO-C; ROO |
NA other |
UNKNOWN | 24 | University of Bari Aldo Moro OTHER |
2020-01-18 |
|
Effectiveness of a Psychoeducation and Support Protocol by Phone in the Aid of Caregivers of Patients With Dementia. NCT03260608 Telesupport Runs in: Brazil · 1 site |
NA other |
UNKNOWN | 148 | Hospital de Clinicas de Porto Alegre OTHER |
2020-01-14 |
|
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease NCT03676881 Computerized cognitive battery: Cognigram (CG); The NeuroCatch™ Pla... Runs in: Canada · 1 site |
NA other |
UNKNOWN | 36 | Bruyère Health Research Institute. OTHER |
2020-01-14 |
|
A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease NCT01458470 Memantine; Placebo Runs in: Canada · 1 site |
PHASE2 symptomatic-cholinergic |
COMPLETED | 19 | University of British Columbia OTHER |
2020-01-13 |
|
A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease NCT02660983 Donepezil hydrochloride; Donepezil matching placebo; Donepezil hydr... Runs in: South Korea · 31 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 302 | Eisai Co., Ltd. INDUSTRY |
2020-01-10 |
|
Vaccination Uptake (VAX) in PD NCT02874274 Standard of Care; Home Visit Program (HVP) Runs in: United States · 1 site |
NA other |
COMPLETED | 164 | NYU Langone Health OTHER |
2020-01-10 |
|
The China Longitudinal Aging Study of Cognitive Impairment NCT03672448 Naturalistic observation Runs in: China · 1 site |
NA other |
UNKNOWN | 10,000 | Shanghai Mental Health Center OTHER |
2020-01-10 |
|
Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia NCT02453932 Tianzhi granule and placebo identified to donepezil; Donepezil and ... Runs in: China · 1 site |
PHASE3 symptomatic-cholinergic |
COMPLETED | 543 | Dongzhimen Hospital, Beijing OTHER |
2020-01-07 |
|
A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's Disease NCT02464293 Mindfulness-based cognitive therapy Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 16 | Lancaster University OTHER |
2020-01-07 |
|
Effects of Transcranial Direct Current Stimulation Associated With Cognitive Training in Alzheimer's Disease NCT04220593 tDCS associated with Tcog Runs in: Brazil · 1 site |
NA other |
UNKNOWN | 80 | Federal University of Paraíba OTHER |
2020-01-07 |
|
Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS) NCT03680664 Active tDCS; sham tDCS; MBSR Runs in: Canada · 1 site |
NA other |
COMPLETED | 12 | Centre for Addiction and Mental Health OTHER |
2020-01-06 |
|
Roflumilast and Cognition NCT01433666 roflumilast (EU: Daxas, USA: Daliresp); Placebo; roflumilast Runs in: Netherlands · 1 site |
PHASE2 other |
COMPLETED | 22 | Maastricht University Medical Center OTHER |
2020-01-02 |
|
Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients. NCT02846740 Alpha-Stim®.; Montgomery-Åsberg Depression Rating Scale, Hamilton A... Runs in: United States · 1 site |
NA other |
TERMINATED | 30 | University of Maryland, Baltimore OTHER |
2019-12-26 |
|
Study: Diet and Exercise Study to Improve Brain Blood Flow: Blood Flow Improvement Trial NCT03117829 Diet and Exercise Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | University of Wisconsin, Madison OTHER |
2019-12-26 |
|
Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Health Aging NCT04207502 Runs in: Taiwan · 2 sites |
NA other |
UNKNOWN | 100 | Chang Gung Memorial Hospital OTHER |
2019-12-26 |
|
Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants NCT02640092 [18F]GTP1 Runs in: United States · 16 sites |
PHASE1 other |
COMPLETED | 72 | Genentech, Inc. INDUSTRY |
2019-12-23 |
|
Neurotrack Test Validation Protocol NCT02608021 Runs in: United States · 1 site |
NA other |
COMPLETED | 81 | NYU Langone Health OTHER |
2019-12-20 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial